MUC16 (CA125) is a well-known tumor biomarker utilized in OC screening and is recognized for its immunosuppressive effects by interacting with the Siglec-9 receptor on NK cells, B cells and monocytes (Felder et al. 2019). This evidence concerns the gene MUC16 and neoplasm.